💡A 🆒🆕 Topic: ♟️Nootropics ♟️💡

One user describes starting retatrutide and testing nootropics via Wonderlic scores, finding modafinil gives a small boost while bemethyl plus methylene blue produced a striking change on the second trial. Long-term users note continued use since around 2010 with timing tweaks needed for oral forms. Others clarify retatrutide modulates dopamine to lower reward-pathway firing and impulsivity rather than acting as an agonist, and question methylene blue's value due to toxicity risks at higher doses.

• Modafinil improved Wonderlic completion time and score slightly for one tester
• Methylene blue turned urine blue with no clear first-test cognitive gain but a strong effect on retest
• Retatrutide appears to reduce impulsivity through dopamine modulation in the reward pathway
• Oral nootropics may require timing adjustments for ongoing users
• Methylene blue shows limited benefits in research and becomes toxic at higher doses

Whether methylene blue provides meaningful cognitive benefits or is mainly ineffective and risky at scale

Long-term outcomes or reliable cognitive gains from combining these compounds with retatrutide

Nothing here is advice.